Authors:
Loukola, A
Eklin, K
Laiho, P
Salovaara, R
Kristo, P
Jarvinen, H
Mecklin, JP
Launonen, V
Aaltonen, LA
Citation: A. Loukola et al., Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC), CANCER RES, 61(11), 2001, pp. 4545-4549
Authors:
Kiuru, M
Launonen, V
Hietala, M
Aittomaki, K
Vierimaa, O
Salovaara, R
Arola, J
Pukkala, E
Sistonen, P
Herva, R
Aaltonen, LA
Citation: M. Kiuru et al., Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology, AM J PATH, 159(3), 2001, pp. 825-829
Authors:
Zhou, XP
Woodford-Richens, K
Lehtonen, R
Kurose, K
Aldred, M
Hampel, H
Launonen, V
Virta, S
Pilarski, R
Salovaara, R
Bodmer, WF
Conrad, BA
Dunlop, M
Hodgson, SV
Iwama, T
Jarvinen, H
Kellokumpu, I
Kim, JC
Leggett, B
Markie, D
Mecklin, JP
Neale, K
Phillips, R
Piris, J
Rozen, P
Houlston, RS
Aaltonen, LA
Tomlinson, IPM
Eng, C
Citation: Xp. Zhou et al., Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes, AM J HU GEN, 69(4), 2001, pp. 704-711
Authors:
Sarantaus, L
Huusko, P
Eerola, H
Launonen, V
Vehmanen, P
Rapakko, K
Gillanders, E
Syrjakoski, K
Kainu, T
Vahteristo, P
Krahe, R
Paakkonen, K
Hartikainen, J
Blomqvist, C
Lopponen, T
Holli, K
Ryynanen, M
Butzow, R
Borg, A
Arver, BW
Holmberg, E
Mannermaa, A
Kere, J
Kallioniemi, OP
Winqvist, R
Nevanlinna, H
Citation: L. Sarantaus et al., Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland, EUR J HUM G, 8(10), 2000, pp. 757-763
Authors:
Launonen, V
Mannermaa, A
Stenback, F
Kosma, VM
Puistola, U
Huusko, P
Anttila, M
Bloigu, R
Saarikoski, S
Kauppila, A
Winqvist, R
Citation: V. Launonen et al., Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables, CANC GENET, 122(1), 2000, pp. 49-54
Authors:
Launonen, V
Avizienyte, E
Loukola, A
Laiho, P
Salovaara, R
Jarvinen, H
Mecklin, JP
Oku, A
Shimane, M
Kim, HC
Kim, JC
Nezu, J
Aaltonen, LA
Citation: V. Launonen et al., No evidence of Peutz-Jeghers syndrome gene LKB1 involvement in left-sided colorectal carcinomas, CANCER RES, 60(3), 2000, pp. 546-548
Authors:
Laake, K
Launonen, V
Niederacher, D
Gudlaugsdottir, S
Seitz, S
Rio, P
Champeme, MH
Bieche, I
Birnbaum, D
White, G
Sztan, M
Sever, N
Plummer, S
Osorio, A
Broeks, A
Huusko, P
Spurr, N
Borg, A
Cleton-Jansen, AM
van't Veer, L
Benitez, J
Casey, G
Peterlin, B
Olah, E
Varley, J
Bignon, YJ
Scherneck, S
Sigurdardottir, V
Lidereau, R
Eyfjord, J
Beckmann, MW
Winqvist, R
Skovlund, E
Borresen-Dale, AL
Citation: K. Laake et al., Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study, GENE CHROM, 25(3), 1999, pp. 212-221
Authors:
Balci, A
Huusko, P
Paakkonen, K
Launonen, V
Uner, A
Ekmekci, A
Winqvist, R
Citation: A. Balci et al., Mutation analysis of BRCA1 and BRCA2 in Turkish cancer families: a novel mutation BRCA2 3414de14 found in male breast cancer, EUR J CANC, 35(5), 1999, pp. 707-710
Authors:
Huusko, P
Castren, K
Launonen, V
Soini, Y
Paakkonen, K
Leisti, J
Vahakangas, K
Winqvist, R
Citation: P. Huusko et al., Germ-line TP53 mutations in Finnish cancer families exhibiting features ofthe Li-Fraumeni syndrome and negative for BRCA1 and BRCA2, CANC GENET, 112(1), 1999, pp. 9-14
Authors:
Launonen, V
Laake, K
Huusko, P
Niederacher, D
Beckmann, MW
Barkardottir, RB
Geirsdottir, EK
Gudmundsson, J
Rio, P
Bignon, YJ
Seitz, S
Scherneck, S
Bieche, I
Champeme, MH
Birnbaum, D
White, G
Varley, J
Sztan, M
Olah, E
Osorio, A
Benitez, J
Spurr, N
Velikonja, N
Peterlin, B
Borg, A
Cleton-Jansen, AM
Devilee, P
Bloigu, R
Lidereau, R
Borresen-Dale, AL
Winqvist, R
Citation: V. Launonen et al., European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables, BR J CANC, 80(5-6), 1999, pp. 879-882
Authors:
Launonen, V
Stenback, F
Puistola, U
Bloigu, R
Huusko, P
Kytola, S
Kauppila, A
Winqvist, R
Citation: V. Launonen et al., Chromosome 11q22.3-q25 LOH in ovarian cancer: Association with a more aggressive disease course and involved subregions, GYNECOL ONC, 71(2), 1998, pp. 299-304